Development of multidose thermotolerant formulations of a vector-based Covid-19 vaccine candidate, NDV-HXP-S in different product formats: Stability and preservative efficacy study
-
Published:2024-10
Issue:
Volume:20
Page:100535
-
ISSN:2590-1362
-
Container-title:Vaccine: X
-
language:en
-
Short-container-title:Vaccine: X
Author:
Bzami Anan,
Zhu Changcheng,
Estrada Marcus,
White Jessica A.ORCID,
Lal ManjariORCID
Reference21 articles.
1. Vaccine instability in the cold chain: Mechanisms, analysis and formulation strategies;Kumru;Biol J Int Assoc Biol Stand,2014
2. Management of COVID-19 vaccines cold chain logistics: A scoping review;Fahrni;J Pharm Policy Pract,2022
3. A Newcastle disease virus expressing a stabilized spike protein of SARS-CoV-2 induces protective immune responses;Sun;Nat Commun,2021
4. Safety and immunogenicity of an egg-based inactivated Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomized, placebo-controlled, phase 1/2 trial in Vietnam;Duc Dang;Vaccine,2022
5. Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomised, placebo-controlled, phase 1 trial;Pitisuttithum;eClinicalMedicine,2022